🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

403 results for “Institut für biomedizinische Analytik NMR-Imaging GmbH” Clear

  1. SEVOFLURANE, DEXMEDETOMIDINE HYDROCHLORIDE

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Children under the age of 2 years having surgery lasting at least 2 hours

    phase 3 small molecule active

    1 trial

  2. STAMARIL® , poeder en oplosmiddel voor suspensie voor injectie in voorgevulde spuit. Gelekoortsvaccin (levend)., STAMARIL® , poeder en oplosmiddel voor suspensie voor injectie in voorgevulde spuit. Gelekoortsvaccin (levend)., STAMARIL® , poeder en oplosmiddel voor suspensie voor injectie in voorgevulde spuit. Gelekoortsvaccin (levend).

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Yellow fever

    phase 3 small molecule active

    1 trial

  3. Sevoflurano Baxter 100% líquido para inhalación del vapor EFG, Propofol Fresenius 20 mg/ml emulsión inyectable y para perfusión EFG

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Acute ischemic stroke

    phase 3 small molecule active

    1 trial

  4. Simvastatina NORMON 10 mg comprimidos recubiertos con película EFG, Atorvastatina NORMON 20 mg comprimidos recubiertos con película EFG, Simvastatina NORMON 40 mg comprimidos recubiertos con película EFG, Atorvastatina NORMON 40 mg comprimidos recubiertos con película EFG, Atorvastatina NORMON 10 mg comprimidos recubiertos con película EFG, Atorvastatina Normon 60 mg comprimidos recubiertos con película, Simvastatina NORMON 20 mg comprimidos recubiertos con película EFG

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Spontaneous lobar ICH

    phase 3 small molecule active

    1 trial

  5. Skilarence 120 mg gastro-resistant tablets, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Adrenomyeloneuropathy

    phase 3 small molecule active

    1 trial

  6. Suspension of autologous mononuclear cells separated from bone marrow aspirate

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    diabetic foot syndrome, lower limb ischemia

    phase 3 small molecule active

    1 trial

  7. TRIGON DEPOT 40 mg/ml suspensión inyectable.

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Chronic shoulder pain

    phase 3 small molecule active

    1 trial

  8. TROMALYT 150 mg cápsulas duras de liberación prolongada

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Women infertility

    phase 3 small molecule active

    1 trial

  9. Tamoxifen Viatris 20 mg tabletter.

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Breast Cancer

    phase 3 small molecule active

    1 trial

  10. Testosterone Gel 1%, Decapeptyl diario 0,1 mg polvo y disolvente para solución inyectable, Astarté 0,25 mg/0,5 ml solución inyectable en jeringa precargada EFG, Bemfola 300 IU/0.50 mL solution for injection in pre-filled pen, Bomba de gel transparente, donde la sustancia activa (testosterona) fue sustituida por agua purificada.

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism

    phase 3 small molecule active

    1 trial

  11. The placebo tablet composition is: Collodial silicone dioxide, Magnesium stearate, Carmellose sodium, Cellulosa powder. Appearance and size will be the same for active and placebo., Trombyl 160 mg tabletter

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Colon and rectal cancer tumor stage II-III, tumor with somatic alterationsin PIK3CA, PIK3R1 or PTEN

    phase 3 small molecule active

    1 trial

  12. Tibsovo 250 mg film-coated tablets

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    ivosidenib maintenance after SOC adjuvant chemotherapy in curative mIDH1 cholangiocarcinoma

    phase 3 small molecule active

    1 trial

  13. Trulicity 0.75 mg solution for injection in pre-filled pen

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Preventive treatment of post-kidney transplant diabetes

    phase 3 small molecule active

    1 trial

  14. Trulicity 0.75 mg solution for injection in pre-filled pen

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Metabolic syndrome in patients on the waiting list for kidney transplantation, Metabolic syndrome in patients on the waiting list for kidney transplantation

    phase 3 small molecule active

    1 trial

  15. Vidaza 25 mg/ml powder for suspension for injection, AG-120/S95031 250mg film-coated tablet

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Hypomethylating agent (HMA) naive myelodysplastic syndromes Myelodysplastic Symdrome (MDS), Myelodysplastic Symdrome (MDS)

    phase 3 small molecule active

    1 trial

  16. Vidaza 25 mg/ml powder for suspension for injection, AG-120/S95031 250mg film-coated tablet, Placebo to Match AG-120 Tablet, 250 mg, is supplied as a film-coated tablet for oral administration.

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Previously Untreated Acute Myeloid Leukemia with an IDH1 Mutation

    phase 3 small molecule active

    1 trial

  17. Vidaza 25 mg/ml powder for suspension for injection, Venclyxto 100 mg film-coated tablets

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Acute Myeloid Leukemia, ONCOLOGY

    phase 3 small molecule active

    1 trial

  18. Zoladex 3,6 mg implante en jeringa precargada, Decapeptyl semestral 22,5 mg polvo y disolvente para suspensión de liberación prolongada inyectable., Eligard semestral 45 mg polvo y disolvente para solución inyectable., Bicalutamida Aristo 50 mg comprimidos recubiertos con película EFG

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Prostate Cancer

    phase 3 small molecule active

    1 trial

  19. innohep® 10.000 anti Xa IU/0,5mL PF.SYR. Ενέσιμο διάλυμα, innohep® 18.000 anti Xa IU/0,9mL PF.SYR. Ενέσιμο διάλυμα, innohep® 14.000 anti Xa IU/0,7mL PF.SYR. Ενέσιμο διάλυμα

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Thromboprophylaxis in patients with advanced pancreatic cancer

    phase 3 small molecule active

    1 trial

  20. -

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Cytomegalovirus infection post allogeneic allogeneic HLA-identical familial PHT

    phase 2 small molecule active

    1 trial

  21. -, CYCLOPHOSPHAMIDE, Cesnicabtagene autoleucel, PARACETAMOL, FLUDARABINE, LENALIDOMIDE, RoActemra 20 mg/mL concentrate for solution for infusion

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Plasma cell leukaemia

    phase 2 small molecule active

    1 trial

  22. 68Ga-FAPI-46

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Triple-negative breast cancer (TNBC) patients at high risk of relapse

    phase 2 small molecule active

    1 trial

  23. 68Ga-FAPI-46

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Non-metastatic Pancreatic ductal adenocarcinoma

    phase 2 small molecule active

    1 trial

  24. 89Zr-Trastuzumab_IJB, Herceptin 150 mg powder for concentrate for solution for infusion, TRASTUZUMAB EMTANSINE

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    advanced/metastatic HER2-positive breast carcinoma

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources